Jesus S - Search Results

1

Immune response elicited by an intranasally delivered HBsAg low-dose adsorbed to poly-ε-caprolactone based nanoparticles.

Jesus S, Soares E, Costa J, Borchard G, Borges O. Jesus S, et al. Int J Pharm. 2016 May 17;504(1-2):59-69. doi: 10.1016/j.ijpharm.2016.03.013. Epub 2016 Mar 11. Int J Pharm. 2016. PMID: 26976502

2

Chitosan-based nanoparticles as a hepatitis B antigen delivery system.

Lebre F, Bento D, Jesus S, Borges O. Lebre F, et al. Among authors: jesus s. Methods Enzymol. 2012;509:127-42. doi: 10.1016/B978-0-12-391858-1.00007-1. Methods Enzymol. 2012. PMID: 22568904

3

Poly-ε-caprolactone/Chitosan and Chitosan Particles: Two Recombinant Antigen Delivery Systems for Intranasal Vaccination.

Jesus S, Soares E, Borges O. Jesus S, et al. Methods Mol Biol. 2016;1404:697-713. doi: 10.1007/978-1-4939-3389-1_45. Methods Mol Biol. 2016. PMID: 27076331

4

The Inclusion of Chitosan in Poly-ε-caprolactone Nanoparticles: Impact on the Delivery System Characteristics and on the Adsorbed Ovalbumin Secondary Structure.

Jesus S, Fragal EH, Rubira AF, Muniz EC, Valente AJM, Borges O. Jesus S, et al. AAPS PharmSciTech. 2018 Jan;19(1):101-113. doi: 10.1208/s12249-017-0822-1. Epub 2017 Jun 13. AAPS PharmSciTech. 2018. PMID: 28612189

5

Poly-ϵ-caprolactone/chitosan nanoparticles provide strong adjuvant effect for hepatitis B antigen.

Jesus S, Soares E, Borchard G, Borges O. Jesus S, et al. Nanomedicine (Lond). 2017 Oct;12(19):2335-2348. doi: 10.2217/nnm-2017-0138. Epub 2017 Sep 4. Nanomedicine (Lond). 2017. PMID: 28868964

6

Oral hepatitis B vaccine: chitosan or glucan based delivery systems for efficient HBsAg immunization following subcutaneous priming.

Soares E, Jesus S, Borges O. Soares E, et al. Among authors: jesus s. Int J Pharm. 2018 Jan 15;535(1-2):261-271. doi: 10.1016/j.ijpharm.2017.11.009. Epub 2017 Nov 11. Int J Pharm. 2018. PMID: 29133207

7

Adjuvant Activity of Poly-ε-caprolactone/Chitosan Nanoparticles Characterized by Mast Cell Activation and IFN-γ and IL-17 Production.

Jesus S, Soares E, Borchard G, Borges O. Jesus S, et al. Mol Pharm. 2018 Jan 2;15(1):72-82. doi: 10.1021/acs.molpharmaceut.7b00730. Epub 2017 Dec 7. Mol Pharm. 2018. PMID: 29160080

8

Chitosan:β-glucan particles as a new adjuvant for the hepatitis B antigen.

Soares E, Jesus S, Borges O. Soares E, et al. Among authors: jesus s. Eur J Pharm Biopharm. 2018 Oct;131:33-43. doi: 10.1016/j.ejpb.2018.07.018. Epub 2018 Jul 23. Eur J Pharm Biopharm. 2018. PMID: 30048745

9

Exosomes as adjuvants for the recombinant hepatitis B antigen: First report.

Jesus S, Soares E, Cruz MT, Borges O. Jesus S, et al. Eur J Pharm Biopharm. 2018 Dec;133:1-11. doi: 10.1016/j.ejpb.2018.09.029. Epub 2018 Oct 1. Eur J Pharm Biopharm. 2018. PMID: 30287267

10

Chitosan Plus Compound 48/80: Formulation and Preliminary Evaluation as a Hepatitis B Vaccine Adjuvant.

Bento D, Jesus S, Lebre F, Gonçalves T, Borges O. Bento D, et al. Among authors: jesus s. Pharmaceutics. 2019 Feb 9;11(2):72. doi: 10.3390/pharmaceutics11020072. Pharmaceutics. 2019. PMID: 30744102 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

344 results

Search Page

Filters